D Matzilevich

Plain English
This study looked at mesenchymal stem cells (MSC) from various tissues and found that they differ in their ability to produce certain proteins and change into different types of cells. Notably, MSC from fetal sources can replicate more times before aging (senescence) compared to those from adults. Understanding these differences will allow doctors to choose the best type of stem cell for specific medical treatments. Who this helps: This helps patients needing tailored stem cell therapies.

Plain English
This study looked at specific brain cells called GABA cells in the hippocampus of people with schizophrenia and bipolar disorder to understand how they work differently in these conditions. Researchers found that there are fewer active GABA cells in the brains of individuals with these disorders, and that these changes may be influenced by different genetic factors and how these cells interact with other brain systems. This research helps explain changes in brain functioning linked to mental health conditions, which could lead to better treatments. Who this helps: This helps patients with schizophrenia and bipolar disorder by improving our understanding of their conditions.

Plain English
This study looked at how certain genes affect a key brain chemical, GABA, in people with schizophrenia and bipolar disorder. It found that a critical marker for GABA, called GAD(67), was significantly reduced in a specific area of the brain (CA2/3) for both conditions, while different genes showed varying expression changes in each disorder. These findings highlight that GABA problems in schizophrenia may be tied to changes at a genetic level, while bipolar disorder may involve issues with cell growth and differentiation. Who this helps: Patients with schizophrenia and bipolar disorder.

Plain English
This study looked at the activity of certain genes related to cell death (apoptosis) in people with bipolar disorder (BD) and schizophrenia (SZ). The researchers found that in bipolar disorder, 19 out of 44 apoptosis-related genes were more active than normal, while in schizophrenia, these genes were less active. Understanding these differences is important because it may lead to better-targeted treatments for each condition. Who this helps: This helps doctors and patients with bipolar disorder and schizophrenia.

Plain English
This study looked at how stress affects certain genes in the brains of rodents that can model schizophrenia. Researchers found that specific genes in the hippocampus, which are linked to stress and emotional responses, change their activity in clusters on particular chromosomes, with the most notable clustering seen on chromosome 1. Importantly, these genes do not appear to be directly linked to known genetic factors for schizophrenia, suggesting that environmental influences might play a significant role in the disorder. Who this helps: This research aids scientists and doctors who are trying to understand the genetic factors involved in schizophrenia and how environmental stress might impact these genes.

Plain English
This study looked at a specific enzyme involved in energy production in the brains of people with bipolar disorder (BPD) compared to those without the condition. Researchers found that levels of creatine kinase messenger RNA were lower in certain brain areas of individuals with BPD, which could help explain why people with BPD have less energy in their brain cells. Specifically, they found this downregulation in the hippocampus and dorsolateral prefrontal cortex, important areas for mood and decision-making. Understanding these changes can help improve treatment strategies for bipolar disorder. Who this helps: This helps patients with bipolar disorder and their doctors.

Plain English
Researchers studied how activation of a brain area called the amygdala affects gene activity in another area called the hippocampus in rats, which serves as a model for schizophrenia. They found that this activation led to increased expression of genes related to 18 different receptors involved in brain signaling, with specific increases noted in receptors that interact with the antipsychotic drug clozapine. This matters because it shows how the amygdala may influence the biology of psychosis, potentially guiding future treatments. Who this helps: This helps patients struggling with schizophrenia and other psychotic disorders.

Plain English
This study looked at how gene activity differs between two important brain areas, the frontal cortex and the hippocampus, both before and after a brain injury. Researchers found that there were significant differences in the levels of 65 genes between the two areas when healthy, and after a specific type of brain injury, 341 genes in the frontal cortex showed changes in their activity. Understanding these differences is important because it could help in developing better treatments for brain injuries, especially since the frontal cortex can recover better than the more vulnerable hippocampus. Who this helps: This helps patients recovering from traumatic brain injuries.

Plain English
Researchers studied how two liver proteins (CYP 4F4 and 4F5) change during infections and brain injuries. They found that these proteins drop by 40-50% during infections, but after brain injury they first disappear and then come roaring back over the following two weeks. This matters because these proteins control inflammatory chemicals in the body—substances that cause swelling and pain. The initial drop after injury allows inflammation to happen (which is actually necessary for healing), but as the proteins return to normal levels, they shut down that inflammation so the body can repair itself and recover.

Plain English
This study looked at how brain injury changes the activity of genes in the hippocampus, a part of the brain important for forming memories. Researchers examined over 8,800 genes and found that about 6% showed changes in their activity after an injury, highlighting the role of inflammation, stress, and metabolism in brain recovery. Understanding these gene changes can help develop better treatments for people suffering from memory problems after traumatic brain injury. Who this helps: This helps patients recovering from traumatic brain injuries.

Plain English
This study focused on a specific protein, called TCNA, produced by the parasite Trypanosoma cruzi, which helps the parasite invade human cells. Researchers found that TCNA is made up of 1,162 amino acids and contains features similar to proteins found in bacteria and humans, including a unique region that could help the parasite attach to host cells more effectively. Understanding these features is important because they could reveal new ways to stop T. cruzi infections, which can lead to illnesses like Chagas disease. Who this helps: This research benefits patients at risk for Chagas disease and doctors treating these infections.